Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-31

Clinical Trial Update: Choroidal Morphology Changes After Aflibercept Therapy in Pachychoroid Neovasculopathy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial from Kim's Eye Hospital reports on changes in choroidal morphology after aflibercept therapy in pachychoroid neovasculopathy; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aflibercept (Aflibercept)

Snippet

Sponsor: Kim's Eye Hospital | Conditions: Pachychoroid Neovasculopathy | Phase 4 | Status: COMPLETED